Videos

Metrics discusses benzophenone migration at AAPS

Metrics discusses benzophenone migration at AAPS

By Gareth Macdonald

US Contract research laboratory Metrics reveals that benzophenone, a component used in varnish on labels, is able to migrate through HDPE bottles to reach the pills inside.

West to add CZ vials as glass QC issues drive interest

West to add CZ vials as glass QC issues drive interest

By Nick Taylor

Recognition of glass vial quality issues is supporting interest in West’s analytical capabilities and Crystal Zenith (CZ) products, new sizes of which are being developed, said a company VP.

Endeavour sees recovery in intermediates sector

Endeavour sees recovery in intermediates sector

By Gareth Macdonald

Drug industry demand for chemical intermediates and development projects has rebounded significantly in the last 12 months according to UK group Endeavour Specialty Chemicals.

IDT sees big potential in vaccine contracting

IDT sees big potential in vaccine contracting

By Gareth Macdonald and Claire Videau

IDT Biologika.says demand for vaccines in emerging markets is big chance for Big Pharma and hence a growing niche for contractors with the technical capabilities to carry out such work.

Falsified APIs and gangsters in the pharma industry

Falsified APIs and gangsters in the pharma industry

By Nick Taylor

Guy Villax, board member of the EFCG, talks falsified APIs, EU efforts to tackle the issue, and the presence of gangsters in the pharma industry in an in-PharmaTechnologist video interview.

An exclusive look inside SAFC's HPAPI plant in Verona, Wisconsin

Special Video Report

An exclusive look inside SAFC's HPAPI plant in Verona, Wisconsin

By Claire Videau and Gareth Macdonald

Greater recognition of toxicity risks of HPAPIs and continued growth of oncology sector are driving drug industry demand for safe manufacturing capacity says US fine molecules firm SAFC Pharma.

IPT at Interphex 2010

IPT at Interphex 2010

By Claire Videau and Gareth Macdonald

Next week in-Pharmatechnologist heads for the excitement, energy and razamatazz of New York, US and Interphex 2010.

RXi targets dermal cells with RNA delivery method

RXi targets dermal cells with RNA delivery method

By Nick Taylor

RXi Pharmaceuticals has applied its sd-rxRNA to dermal cells, establishing the efficacy of the technology as it seeks to move it on to the next stage of development, a company VP told in-PharmaTechnologist.